Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (CTKB)

CUSIP: 23285D109

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+8,527,394
Put/Call ratio
5.4%
SEC-reported price per share
$8.54
Number of holders
100
Value change
+$69,958,551
Number of buys
73
Open additional details 1 more signal available
Number of sells
43
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
129,063,934

Security key

23285D109

Report period

Q2 2023

Institutions

100

Top holders

10

Ownership snapshot

Top reported holders of CTKB - Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2023
3/4/5 13F Lead comparable stake: 10% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 10%
BROWN CAPITAL MANAGEMENT LLC 6.7%
BlackRock Finance, Inc. 6.4%
VANGUARD GROUP INC 6.1%
HHLR ADVISORS, LTD. 6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
3/4/5 13F
Director, 10%+ Owner · Company
10%
from 13F
$127,120,013
13,381,054 shares
14 Mar 2022
BROWN CAPITAL MANAGEMENT LLC
13F
Company
13F
6.7%
$79,047,077
8,601,423 shares
31 Mar 2023
BlackRock Finance, Inc.
13F
Company
13F
6.4%
$76,159,799
8,287,247 shares
31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
6.1%
$72,467,635
7,885,488 shares
31 Mar 2023
HHLR ADVISORS, LTD.
13F
Company
13F
6%
$70,795,294
7,703,514 shares
31 Mar 2023
STATE STREET CORP
13F
Company
13F
1.6%
$18,924,710
2,059,272 shares
31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
100
Shares
77,036,054
Rows available
100
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
100
Q2 2023 holders
100
Holder diff
0
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .